Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Securecell AG
About
  2. Companies
  3. Securecell AG
  4. Products
  5. Seraccess - Model SENSE - Unrivalled ...

Seraccess - Model SENSE - Unrivalled Artificial Pancreas for Unmanageable Diabetes

SHARE

Seraccess® was forged from Securecell’s expertise in automating and digitalizing the biotechnology space. Our immense knowledge of connecting expansive bioprocessing systems, microfluidics and documenting processes down to the molecular level led us to solutions that could greatly impact the Artificial Pancreas Device System (APDS) market for a significantly underserved diabetes community: unstable type 1 or 2 diabetes patients.1

Most popular related searches
blood glucose
diabetes patient
lower limb amputation
diabetes
glucose level
pancreas
subcutaneous tissue
lower limbs
limb amputation
heart attack

Seraccess® was forged from Securecell’s expertise in automating and digitalizing the biotechnology space. Our immense knowledge of connecting expansive bioprocessing systems, microfluidics and documenting processes down to the molecular level led us to solutions that could greatly impact the Artificial Pancreas Device System (APDS) market for a significantly underserved diabetes community: unstable type 1 or 2 diabetes patients.1

How We Change the Game

Current APDS* cannot alleviate the hardship known as unmanageable diabetes.

This disease causes sudden, frequent unpronounced and dramatic swings in blood glucose levels that trigger life-threatening episodes (hypoglycemia or hyperglycemia) due to insufficient precision and time delay of testing and infusing within the subcutaneous tissue. Substantially impaired quality of life and unnecessary excessive economic costs (generated by several emergency interventions per year) keep patients in a constant state of flux from a storm that never quells and uncertainty that never dissipates.

Seraccess® SENSE greatly lightens that burden by offering a more effective solution that operates nearly in real time and in direct communication with the patient's bloodstream.

This nearly delay-free, highly accurate and precise blood glucose measurement allows Seraccess® SENSE to administer the exact amount of insulin needed directly into the vein with immediate effect, redirecting unruly blood glucose levels into the target range.**

Sudden, unpredictable and uncontrollable swings in blood glucose that significantly disrupt almost every aspect of life for those with unmanageable diabetes.

Immediate Complications
  • Life Threatening Hypo / Hyperglycemic Attack
  • Loss of Consciousness
  • Death
Mid / Long-term Complications
  • Lower Limb Amputations (Neuropathy)
  • Heart Attacks
  • Strokes (Cardiovascular Disease)
  • Blindness (Retinopathy)
  • Kidney Failure
  • Significantly Increased Mortality Rate

The only alternative treatments for some of these patients are pancreas or islet cell transplantation (requiring life-long immuno suppressive therapy with severe side effects).

Additionally, these patients suffer from aconstantly disrupted quality of life and greatly impaired personal and social relationships.

Current standard treatments fail to help this subset of diabetes patients, resulting in enormous economic burdens of up to 500K USD per year, per patient, due to frequent emergency hospitalizations.2 We can help cut this cost by 80% or more.2